Papers on seroconversion
53 papers1 new in 30 days
Wednesday, November 4
Tuesday, September 22
Thursday, September 10
Tuesday, June 30
Trends in Biosciences Research
IMMUNE RESPONSE VARIABILITY FOLLOWING VACCINATION IN DIFFERENT AGE GROUPS
Computational studyImmune response
Sunday, April 19
BMC Infectious Diseases
Telomere length dynamics in adults living with HIV: A systematic review
Systematic review of observational studiesTelomere length
Thursday, February 26
Wednesday, September 4
Frontiers in Immunology
Immunogenicity and safety of different combinations involving a third booster dose of SARS-CoV-2 inactivated vaccine, inactivated quadrivalent influenza vaccine, and 23-valent pneumococcal polysaccharide vaccine in adults aged ≥60 years: a phase 4, randomized, open-label study
Randomized trial in 636 peopleInterventions
Wednesday, February 28
NPJ Vaccines
Immunisation efficacy of a stabilised SARS-CoV-2 spike glycoprotein in two geriatric animal models
Experiments in hamstersInterventions
Friday, November 24
The Journal of Nutrition, Health & Aging
Frailty and Humoral Immune Responses Following COVID-19 Vaccination among Patients Undergoing Hemodialysis
Cohort study of 206 peoplePopulations
Friday, July 28
Immunity & Ageing
Immunogenicity and safety of quadrivalent influenza vaccine among young and older adults in Tianjin, China: implication of immunosenescence as a risk factor
Non-randomized trial in 167 peopleInterventions
Saturday, April 8
International Urology and Nephrology
The impact of frailty syndrome on humoral response to SARS-CoV-2 mRNA vaccines in older kidney transplant recipients
Cohort study of 101 peopleBiomarkers
Thursday, March 30
Biomedicines
COVID-19 in Older Patients: Assessment of Post-COVID-19 Sarcopenia
Cohort study of 106 peopleCOVID-19
Thursday, November 3
NPJ Vaccines
DYNAMIC cohort study evaluating metabolic predictors of influenza vaccine immune response in older adults
Cohort study of 234 peopleInfluenza
Thursday, June 16
PLOS One
Physical activity and acute exercise benefit influenza vaccination response: A systematic review with individual participant data meta-analysis
Meta-analysis of randomized trialsPhysical activity
Wednesday, May 11
Friday, April 22
The Journals of Gerontology, Series A
Frailty and COVID-19 mRNA Vaccine Antibody Response in the COVID-19 Community Research Partnership
Cohort study of 1,677 peopleBiomarkers
Friday, April 15
Journal of Medical Virology
Sequential IgG antibody monitoring for virus-inactivated and adenovirus-vectored COVID-19 vaccine in Brazilian healthcare workers
Cohort study in peopleCOVID-19
Sunday, March 27
Vaccines
Humoral and Cellular Response after mRNA Vaccination in Nursing Homes: Influence of Age and of History of COVID-19
Cohort study of 1,973 peopleCOVID-19
Friday, March 18
Frontiers in Genetics
Increased Rate of Epigenetic Aging in Men Living With HIV Prior to Treatment
Cohort study in peopleBiomarkers
Wednesday, January 12
Nature Communications
Population homogeneity for the antibody response to COVID-19 BNT162b2/Comirnaty vaccine is only reached after the second dose across all adult age ranges
Cohort study of 1,245 peopleInterventions
Thursday, November 25
Journal of Virology
Age-Related Susceptibility of Ferrets to SARS-CoV-2 Infection
Experiments in animalsMechanisms
Saturday, October 30
Human Vaccines & Immunotherapeutics
Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people aged 60 years or older: a randomized Phase III trial
Randomized trial in 1,528 peopleInfluenza
Wednesday, October 27
Science Translational Medicine
GRAd-COV2, a gorilla adenovirus-based candidate vaccine against COVID-19, is safe and immunogenic in younger and older adults
Non-randomized trial in 90 peopleCOVID-19
Saturday, October 2
PLOS Medicine
Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: A phase 2 randomized placebo-controlled trial
Randomized trial in 1,283 peopleInterventions
Friday, July 23
Nature Microbiology
Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom
Cohort study of 45,965 peopleInterventions
Friday, July 2
Sunday, June 27
Clinical Microbiology and Infection
B- and T-cell immune responses elicited by the Comirnaty® COVID-19 vaccine in nursing-home residents
Study in peopleCOVID-19
Tuesday, June 15
Journal of the American Geriatrics Society
Hand grip strength before and after SARS-CoV-2 infection in community-dwelling older adults
Cohort study of 254 peoplePopulations
Monday, May 17
medRxiv
Phase 2 Randomized Trial of an AS03 Adjuvanted Plant-Based Virus-Like Particle Vaccine for Covid-19 in Healthy Adults, Older Adults and Adults with Comorbidities
Preprint: randomized trial in 753 peopleCOVID-19
